Learn how Medtronic is moving to mark Arctic Front a first-line treatment for atrial fibrillation
In this episode, Rebecca Seidel, president of cardiac ablation solutions, and Dr. Robert Kowal, vice president, medical affairs and CMO of cardiac rhythm and heart failure, detail how Medtronic is targeting atrial fibrillation, a deadly and far-ranging disease, with Artic Front, a delivery of cryoablation therapies. Medtronic secured a first-time FDA approval, which agrees cryoablation should be offered as an initial treatment for people suffering with atrial fibrillation. Medtronic is moving forward with a unique direct-to-consumer approach and bringing insurance companies in on the conversation. The conversation also hits upon the company’s emerging pulse field ablation therapy.